MedPath

Prevention of Liver Damage During Liver Surgery

Phase 1
Conditions
Liver Tumors
Interventions
Drug: placebo
Procedure: Liver resection
Registration Number
NCT00845689
Lead Sponsor
Ludwig-Maximilians - University of Munich
Brief Summary

Liver damage as a consequnce of ischemia (I) and reperfusion (R) is known to harm the liver and could hence be a critical factor of the postoperative outcome of patients undergoing liver surgery. In order to protect the liver from ischemic damage following interventions such as the Pringle Maneuver, preconditioning has been successfully applied in various animal models as well as in humans. Since ischemia inevitably leads to cell hypoxia and subsequnet release of endogenuous metabolites, the investigators hypothesize that instead of brief periods of ischemia, the exogenuous infusion of purine analogues may also protect against subsequent prolonged periods of ischemia. Moreover, after reperfusion, the antiinflamamtory action of purine ananlogue infusion can further attenuated liver damage.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria
  • elective resection of liver tumors
  • age 18 to 80 years
  • informed consent
Exclusion Criteria
  • chronic obstructive pulmonary disease
  • heart insufficiency NYHA III-IV
  • atrio-ventricular conductance blockage II. (Mobitz) or III. degree
  • atrial fibrillation
  • coronary heart disease (CCS III. or IV. degree)
  • arterial hypertension
  • acute renal failure
  • increased intracranial pressure
  • gout
  • pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
1placeboliver resection with Pringle + placebo
1Liver resectionliver resection with Pringle + placebo
2Liver resectionliver resection with Pringle + adenosine preconditiong
3Liver resectionliver resection with Pringle + adenosine pre- and postconditioning
2adenosineliver resection with Pringle + adenosine preconditiong
3adenosineliver resection with Pringle + adenosine pre- and postconditioning
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath